Group 1 - The company announced the repurchase and cancellation of 30,000 restricted stocks due to the death of one of the incentive plan participants, resulting in a reduction of the total share capital by 30,000 yuan [1][2] - The company held its first extraordinary shareholders' meeting of 2026 on January 16, 2026, where the proposal for the repurchase of restricted stocks was approved [7][16] - The shareholders' meeting had a total of 492 participants, representing 257,913,778 shares, which is 34.0340% of the total voting shares [14] Group 2 - The company notified creditors that they have 45 days from the announcement date to claim debts or request guarantees due to the capital reduction [2][5] - The meeting's voting process combined both on-site and online methods, ensuring compliance with legal regulations [12][20] - Legal opinions confirmed that the meeting's procedures and voting results were legitimate and compliant with relevant laws [20]

证券代码：002688 证券简称：金河生物 公告编号：2026-005 金河生物科技股份有限公司 关于回购注销部分限制性股票减少注册资本 暨通知债权人的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、通知债权人的原因 金河生物科技股份有限公司（以下简称"公司"）于 2025 年 12 月 30 日召 开第六届董事会第三十五次会议，于 2026 年 1 月 16 日召开 2026 年第一次临时 股东会，审议通过了《关于回购注销部分限制性股票的议案》。具体内容详见公 司于巨潮资讯网（http://www.cninfo.com.cn）及《证券时报》《中国证券报》 《证券日报》和《上海证券报》披露的相关公告。 债权人如果提出要求本公司清偿债务或提供相应担保的，应根据《公司法》 等相关法律、法规的规定，向公司提出书面要求，并随附相关证明文件。公司债 权人可采用现场、信函或传真的方式申报，具体如下： 1、申报时间：2026 年 1 月 16 日至 2026 年 3 月 1 日 2、申报登记及申报材料送达地点： 地址：内蒙古自治区呼和浩特市新城区兴安北 ...

華 聯 律 師 事 務 所 HuaL ianLa w F irm 中國北京市朝陽區亮马桥路32號高斓大厦10层 郵編: 100125 電話: 8610-84417811 傳真: 8610-84417306 電郵: hualian@hllf.cn 網址: www.hllf.cn 关于金河生物科技股份有限公司二零二六年第一次临时股东会的法律意见书 致：金河生物科技股份有限公司 根据中国证监会发布的《上市公司股东会规则》（下称"《股东会规则》"） 的有关规定，北京市华联律师事务所（下称"本所"）接受金河生物科技股份有 限公司（下称"公司"）的委托，指派赫志律师、崔丽律师出席公司 2026 年第 一次临时股东会（下称"本次股东会"），并就本次股东会的召集和召开程序、 召集人资格、出席会议人员资格、会议的表决程序及表决结果等事宜发表法律意 见。 本所及经办律师依据《中华人民共和国公司法》（以下简称《公司法》）《中 华人民共和国证券法》（以下简称《证券法》）《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及本法律意 见书出具日以前已经发生或者存在的事实，严格履行了法定职责，遵循了 ...

证券代码：002688 证券简称：金河生物 公告编号：2026-004 1、召开时间 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2026 年 1 月 16 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证 券交易所互联网投票系统投票的具体时间为：2026 年 1 月 16 日上午 9:15 至下 午 15:00 期间的任意时间。 2、股权登记日：2026 年 1 月 12 日 3、现场会议召开地点：内蒙古自治区托克托县新坪路 71 号公司三楼会议室 4、会议表决方式：现场投票与网络投票表决相结合的方式 金河生物科技股份有限公司 2026年第一次临时股东会决议的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、本次股东会无否决提案的情形。 2、本次股东会没有涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 金河生物科技股份有限公司（以下简称"公司"）2026 年第一次临时股东 会通知于 2025 年 12 月 31 日在《上海证券报》、《证券时报》、《证券日 ...

Core Viewpoint - The animal health sector experienced a rise of 0.93% on January 16, with leading gains from BioShares, while the overall market indices showed slight declines [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4101.91, down 0.26% [1]. - The Shenzhen Component Index closed at 14281.08, down 0.18% [1]. Group 2: Individual Stock Performance - BioShares (600201) led the gains with a closing price of 17.61, up 3.53%, and a trading volume of 480,000 shares, amounting to a transaction value of 840 million yuan [1]. - Other notable performers included: - Huisheng Bio (300871) at 26.03, up 1.36%, with a transaction value of 434 million yuan [1]. - Xianfeng Holdings (002141) at 3.76, up 1.35%, with a transaction value of 8.13 million yuan [1]. - Ruipu Bio (300119) at 20.15, up 0.90%, with a transaction value of 110 million yuan [1]. - Shunlian Bio (688098) at 9.60, up 0.63%, with a transaction value of 40.84 million yuan [1]. Group 3: Capital Flow - The animal health sector saw a net inflow of 112 million yuan from institutional investors, while retail investors experienced a net outflow of 68.65 million yuan [2]. - The capital flow for individual stocks showed: - BioShares had a net inflow of 75.95 million yuan from institutional investors [3]. - Huisheng Bio had a net inflow of 19.63 million yuan from institutional investors [3]. - Xianfeng Holdings had a net inflow of 16.40 million yuan from institutional investors [3].

Group 1 - The company, Jinhe Biological, announced the return of 80 million yuan of idle raised funds to the special account for raised funds, which was used for temporarily supplementing working capital [2] - The usage period of the returned funds did not exceed 12 months, and the company has informed the sponsor institution accordingly [2]

Market Overview - The animal health sector experienced a decline of 0.44% on January 14, with Haili Biological leading the drop [1] - The Shanghai Composite Index closed at 4126.09, down 0.31%, while the Shenzhen Component Index closed at 14248.6, up 0.56% [1] Stock Performance - Notable gainers included: - Qudongli (code: 920275) with a closing price of 10.39, up 10.65% on a trading volume of 112,300 shares and a turnover of 118 million yuan [1] - Huisheng Biological (code: 300871) closed at 25.52, up 1.84% with a trading volume of 270,100 shares and a turnover of 696 million yuan [1] - Major decliners included: - Haili Biological (code: 603718) closed at 6.55, down 1.65% with a trading volume of 237,400 shares and a turnover of 157 million yuan [2] - Zhongmu Co., Ltd. (code: 600195) closed at 7.92, down 1.61% with a trading volume of 201,400 shares and a turnover of 161 million yuan [2] Capital Flow - The animal health sector saw a net outflow of 140 million yuan from institutional investors, while retail investors experienced a net inflow of 52.14 million yuan [2] - The detailed capital flow for selected stocks showed: - Huisheng Biological had a net inflow of 23.06 million yuan from institutional investors [3] - ST Green Kang (code: 002868) faced a significant net outflow of 5.87 million yuan from institutional investors [3]

Core Viewpoint - The company announced the temporary use of idle raised funds to supplement working capital, with a total amount not exceeding 80 million yuan [1] Group 1 - On September 19, 2025, the company held a meeting to approve the use of up to 80 million yuan of idle raised funds for temporary working capital [1] - The company actually utilized the full amount of 80 million yuan for this purpose [1] - On January 13, 2026, the company fully repaid the funds back to the special account for raised funds and informed the sponsor institution and the sponsor representative [1]

金河生物科技股份有限公司 关于归还暂时补充流动资金的闲置募集资金的公告 证券代码：002688 证券简称：金河生物 公告编号：2026-003 2026 年 1 月 13 日，公司已将上述用于暂时补充流动资金的闲置募集资金 8,000 万元全部归还至募集资金专用账户，使用期限未超过 12 个月。同时，公 司将上述募集资金的归还情况告知了公司保荐机构及保荐代表人。 特此公告。 金河生物科技股份有限公司 董 事 会 2026 年 1 月 14 日 1 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）于 2025 年 9 月 19 日召开 了第六届董事会第三十次会议和第六届监事会第二十五次会议审议通过《关于使 用部分闲置募集资金暂时补充流动资金的议案》。同意公司在确保不影响募集资 金投资项目实施及募集资金使用的情况下，使用不超过 8,000 万元的闲置募集资 金暂时补充公司流动资金，使用期限自董事会审议通过之日起不超过十二个月， 到期归还至募集资金专用账户。具体内容详见公司 2025 年 9 月 20 日于巨潮 ...

Core Viewpoint - The company reported a decline in profits for the third quarter due to routine maintenance in the chemical medicine workshop, the seasonal downturn in industry consumption, increased production capacity from the launch of the sixth phase project, and promotional discounts offered by the company [2] Group 1 - The main reasons for the profit decline include routine maintenance, seasonal consumption downturn, increased production capacity, and promotional discounts [2] - The company raised the price of gold mycin in domestic and other export markets at the end of November, which may positively impact the fourth quarter's performance [2] - Investors are advised to monitor the company's announcements for specific operational updates [2]